InsiderPresident and COO

Julie Rubinstein Insider Trading Activity

Every SEC Form 4 transaction reported by Julie Rubinstein, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Julie Rubinstein buying or selling?

Julie Rubinstein reported 0 open-market buys ($0) and 58 sells ($85.2M) across 58 Form 4 filings at 1 company — a net selling position of $85.2M.

Source: SEC EDGAR Form 4

What stands out

Key Statistics (as of Oct 16, 2026)

Total Form 4 filings
58
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (58)
$85.2M

Insider sentiment

Net selling

Net insider flow of $85.2M in net selling, filed between Dec 27, 2019 – Oct 16, 2026.

Companies Julie Rubinstein files for

#CompanyForm 4 filings
1ADPTAdaptive Biotechnologies Corp58

Recent Julie Rubinstein transactions

DateTickerRoleTypeSharesValueFiling
Oct 16, 2026ADPTPresident and COOSale35.6K$897.4KSEC ↗
Oct 13, 2026ADPTPresident and COOSale35.6K$919.9KSEC ↗
Oct 8, 2026ADPTPresident and COOSale35.6K$948.2KSEC ↗
Oct 6, 2026ADPTPresident and COOSale35.6K$1.0MSEC ↗
Apr 29, 2026ADPTPresident and COOSale19.0K$270.9KSEC ↗
Apr 24, 2026ADPTPresident and COOSale57.2K$798.4KSEC ↗
Apr 21, 2026ADPTPresident and COOSale69.1K$1.0MSEC ↗
Apr 16, 2026ADPTPresident and COOSale57.2K$826.3KSEC ↗
Apr 13, 2026ADPTPresident and COOSale57.2K$758.1KSEC ↗
Apr 8, 2026ADPTPresident and COOSale69.1K$990.5KSEC ↗
Apr 2, 2026ADPTPresident and COOSale38.1K$553.7KSEC ↗
Mar 31, 2026ADPTPresident and COOSale57.2K$751.3KSEC ↗
Mar 26, 2026ADPTPresident and COOSale57.2K$802.2KSEC ↗
Mar 23, 2026ADPTPresident and COOSale57.2K$769.6KSEC ↗
Mar 18, 2026ADPTPresident and COOSale57.2K$762.2KSEC ↗
Mar 14, 2026ADPTPresident and COOSale179.7K$2.4MSEC ↗
Mar 11, 2026ADPTPresident and COOSale81.3K$1.2MSEC ↗
Mar 6, 2026ADPTPresident and COOSale92.8K$1.5MSEC ↗
Mar 7, 2025ADPTPresident and COOSale59.5K$415.5KSEC ↗
Mar 7, 2024ADPTPresidentSale39.1K$135.8KSEC ↗
Mar 9, 2023ADPTPresidentSale22.7K$194.3KSEC ↗
Mar 9, 2022ADPTPresidentSale4.6K$55.4KSEC ↗
Mar 4, 2021ADPTPresidentSale15.0K$874.7KSEC ↗
Mar 2, 2021ADPTPresidentSale15.0K$843.5KSEC ↗
Feb 26, 2021ADPTPresidentSale29.7K$1.7MSEC ↗

Showing the 25 most recent filings of 58. Screen every filing.

Julie Rubinstein insider trading FAQ

Is Julie Rubinstein buying or selling?

Across 58 SEC Form 4 filings, Julie Rubinstein reported 0 open-market purchases totaling $0 and 58 sales totaling $85.2M — a net selling position of $85.2M.

Which companies does Julie Rubinstein file Form 4s for?

Julie Rubinstein has reported insider transactions at 1 company, most often Adaptive Biotechnologies Corp (ADPT).

How far back does Julie Rubinstein's filing history go?

Trabud holds Julie Rubinstein's SEC Form 4 filings from Dec 27, 2019 – Oct 16, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Julie Rubinstein's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Julie Rubinstein and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener